Last reviewed · How we verify

Recombinant FSH (rFSH)

AGUNCO Obstetrics and Gynecology Centre · FDA-approved active Small molecule

Recombinant FSH (rFSH) is a Gonadotropin Small molecule drug developed by AGUNCO Obstetrics and Gynecology Centre. It is currently FDA-approved for Infertility in women undergoing assisted reproductive technology (ART), Anovulation and ovulatory dysfunction in women seeking pregnancy.

Recombinant FSH (follicle-stimulating hormone) stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.

Recombinant FSH (follicle-stimulating hormone) stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment. Used for Infertility in women undergoing assisted reproductive technology (ART), Anovulation and ovulatory dysfunction in women seeking pregnancy.

At a glance

Generic nameRecombinant FSH (rFSH)
SponsorAGUNCO Obstetrics and Gynecology Centre
Drug classGonadotropin
TargetFSH receptor (FSHR)
ModalitySmall molecule
Therapeutic areaReproductive Medicine / Fertility
PhaseFDA-approved

Mechanism of action

rFSH is a recombinant version of the naturally occurring pituitary hormone FSH that binds to FSH receptors on granulosa cells of ovarian follicles, promoting follicular development and estrogen production. This hormone replacement is used in assisted reproductive technology to induce controlled ovarian hyperstimulation, enabling the retrieval of multiple mature oocytes for in vitro fertilization or other fertility procedures.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Recombinant FSH (rFSH)

What is Recombinant FSH (rFSH)?

Recombinant FSH (rFSH) is a Gonadotropin drug developed by AGUNCO Obstetrics and Gynecology Centre, indicated for Infertility in women undergoing assisted reproductive technology (ART), Anovulation and ovulatory dysfunction in women seeking pregnancy.

How does Recombinant FSH (rFSH) work?

Recombinant FSH (follicle-stimulating hormone) stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.

What is Recombinant FSH (rFSH) used for?

Recombinant FSH (rFSH) is indicated for Infertility in women undergoing assisted reproductive technology (ART), Anovulation and ovulatory dysfunction in women seeking pregnancy.

Who makes Recombinant FSH (rFSH)?

Recombinant FSH (rFSH) is developed and marketed by AGUNCO Obstetrics and Gynecology Centre (see full AGUNCO Obstetrics and Gynecology Centre pipeline at /company/agunco-obstetrics-and-gynecology-centre).

What drug class is Recombinant FSH (rFSH) in?

Recombinant FSH (rFSH) belongs to the Gonadotropin class. See all Gonadotropin drugs at /class/gonadotropin.

What development phase is Recombinant FSH (rFSH) in?

Recombinant FSH (rFSH) is FDA-approved (marketed).

What are the side effects of Recombinant FSH (rFSH)?

Common side effects of Recombinant FSH (rFSH) include Ovarian hyperstimulation syndrome (OHSS), Injection site reactions, Headache, Abdominal pain/bloating, Nausea.

What does Recombinant FSH (rFSH) target?

Recombinant FSH (rFSH) targets FSH receptor (FSHR) and is a Gonadotropin.

Related